ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Also M.D. Anderson awarded three new, one renewal SPORE grant.

October 31, 2003

NDA n Vp-16 Goes to Advisory Committee Sept. 30

August 27, 1982

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

August 30, 2013

Researchers Plan to Extend Phase IIa Asonep Trial

August 29, 2014

Study Attributes Drop In Breast Cancer Incidence To Decline In Hormone Replacement.

December 15, 2006

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012